Conclusion:
- among men with low testosterone and normal PSA levels who were followed for a median of 3 years, compared with untreated men, men treated with testosterone were not at increased risk of incident aggressive or any prostate cancer
- the longer term clinical risks and benefits of testosterone treatment can only be definitively addressed by large, long-term randomized controlled trials
http://journals.plos.org/plosone/art...type=printable
- among men with low testosterone and normal PSA levels who were followed for a median of 3 years, compared with untreated men, men treated with testosterone were not at increased risk of incident aggressive or any prostate cancer
- the longer term clinical risks and benefits of testosterone treatment can only be definitively addressed by large, long-term randomized controlled trials
http://journals.plos.org/plosone/art...type=printable
from ExcelMale.com https://ift.tt/2tnyYIo
No comments:
Post a Comment